Advertisement

Introduction to Gynecologic Cancer

  • Georgios E. Hilaris
Chapter

Abstract

One of the key aspects in the assessment of the patient with suspected or known gynecologic cancer is imaging. Upon patient presentation, it is often the next step in its management following a thorough history and detailed physical examination. The role of imaging is equally crucial during the preoperative evaluation as well as during the postoperative surveillance period for the documentation of clinical remission or suspected tumor relapse and/or metastasis.

References

  1. 1.
    Jemal A, Bray F et al (2011) Global cancer statistics. CA Cancer J Clin 61:69CrossRefGoogle Scholar
  2. 2.
    SEER Cancer Statistics (http://seer.cancer.gov)
  3. 3.
    Felix AS, Weissfeld JL, Stone RA et al (2010) Factors associated with type I and type II endometrial cancer. Cancer Causes Control 21(11):1851–1856CrossRefGoogle Scholar
  4. 4.
    Lewin SN, Herzog TJ et al (2010) Comparative performance of the 2009 international federation of gynecology and obstetrics' staging system for uterine corpus cancer. Obstet Gynecol 116(5):1141CrossRefGoogle Scholar
  5. 5.
    Hilaris GE et al (2009) Feasibility safety and cost outcomes of laparoscopic management off early endometrial and cervical malignancy. JSLS 13(4):489–495CrossRefGoogle Scholar
  6. 6.
    Siegel R, Naishadham D et al (2012) Cancer statistics, 2012 CA cancer. J Clin 62(1):10Google Scholar
  7. 7.
    Lacey JV, Sherman ME (2009) Ovarian neoplasia. In: Robboy SL, Mutter GL, Prat J et al (eds) Robboy's pathology of the female reproductive tract, 2nd edn. Churchill Livingstone Elsevier, Oxford, p 601CrossRefGoogle Scholar
  8. 8.
    Prat J (2014) FIGO staging for ovarian, fallopian tube and peritoneal cancer. Gynecol Oncol 133:401–404CrossRefGoogle Scholar
  9. 9.
    Heintz AP, Odicino F, Maisonneuve P et al (2006) Carcinoma of the ovary. Int J Gynaecol Obstet 95:S161CrossRefGoogle Scholar
  10. 10.
    Ries LAG, Melbert D et al (2007) SEER cancer statistics review, 1975–2004. National Cancer Institute, Bethesda, MDGoogle Scholar
  11. 11.
    Siegel R, Ward E et al (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61(4):212CrossRefGoogle Scholar
  12. 12.
    Walboomers JM, Jacobs MV et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1):12CrossRefGoogle Scholar
  13. 13.
    Pecorelli S et al (2009) Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105(2):103CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.2nd Dept. of Gynecologic OncologyHygeia HospitalMarousi, AthensGreece
  2. 2.Division of Gynecologic OncologyStanford University School of MedicineStanfordUSA

Personalised recommendations